Background: Improvement in cardiac function has been demonstrated after thyroxine treatment in humans with hypothyroidism using the myocardial performance index (MPI). Cardiac changes after thyroxine supplementation are poorly documented in dogs with spontaneous hypothyroidism and comparison with clinically healthy dogs is lacking.
reproductive, neurological, and cardiovascular abnormalities. 1, 2 In particular, retrospective clinical and experimental studies reported changes of both cardiac electrical and mechanical functions in dogs with spontaneous and induced thyroid hormone deficiency. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Reported ECG abnormalities in hypothyroid dogs include cardiac arrhythmias, such as sinus bradycardia, 7, 8 atrial fibrillation, [4] [5] [6] 10 and atrioventricular blocks, 7, 9, 12, 14 decreased R wave amplitude, 9, 10, 12, 14 and decreased amplitude or inverted T wave. 10 Partial response to thyroxine treatment with normalization of ECG changes was reported in some dogs, [6] [7] [8] [9] [10] and conversion of atrial fibrillation to sinus rhythm was observed in a dog treated solely with thyroxine. 3 Previous echocardiographic studies in dogs with hypothyroidism have been predominantly focused on evaluation of left ventricular (LV) systolic cardiac function. Echocardiographic changes observed in dogs with spontaneous or experimentally induced hypothyroidism include increased left ventricular diameter in systole (LVDS) and diastole (LVDD), 5, 9 decreased LV fractional shortening (FS), 3, 5 prolonged pre-ejection period, and decreased velocity of circumferential fiber shortening. 9 All of these alterations might mimic a familiar form of primary cardiomyopathy such as dilated cardiomyopathy (DCM). 15 Thus, it was previously thought that hypothyroidism-induced cardiomyopathy should be considered a differential diagnosis for DCM in dogs. 15 However, LV systolic function and time intervals should improve in dogs with hypothyroid-induced cardiac changes when appropriate hormone replacement treatment has been established. 16 In humans, both systolic and diastolic cardiac function can be influenced by thyroid hormones, 17 and the myocardial performance index (MPI), defined as the sum of isovolumetric contraction time plus relaxation time divided by ejection time, has been proposed as a useful marker of combined systolic and diastolic cardiac function. 18, 19 Measurement of MPI in human patients with hypothyroidism showed deterioration of cardiac function that was reversible after treatment with thyroxine. 17, 20 No study has prospectively investigated the effects of naturally occurring hypothyroidism on both systolic and diastolic function using the MPI in dogs. Furthermore, previous studies on cardiac dysfunction in dogs with hypothyroidism were carried out without the use of a control group of clinically healthy dogs. Thus, we evaluated cardiac electrical activity and mechanical function, including measurement of MPI, in euthyroid dogs and dogs with primary hypothyroidism before and after thyroxine supplementation.
| MATERIALS AND METHODS

| Animals
Client-owned dogs presented to 2 veterinary teaching hospitals and with a final diagnosis of primary hypothyroidism were prospectively included in the study. After the owner signed a written consent form, each dog underwent physical examination, ECG, echocardiographic examination, and blood sampling for CBC and serum biochemical profile. Dogs were considered hypothyroid if they showed consistent clinical signs of hypothyroidism (eg, dermatological abnormalities, lethargy, asthenia, exercise intolerance, cold intolerance, obesity, weight gain), serum total thyroxine (TT4), and canine thyrotropin hormone (cTSH) concentrations below and above the reference range, respectively (ie, TT4 <0.93 μg/dL and cTSH >0.5 ng/mL). In dogs with serum TT4 concentration below the reference range and normal serum cTSH concen- A control population of 20 clinically healthy dogs also was enrolled. They were recruited from the patients of the 2 hospitals presented for periodic routine visits or for evaluation before an elective procedure. Dogs were considered healthy on the basis of clinical history and normal results of physical examination, CBC, and serum biochemical profile, including serum TT4 and cTSH concentrations (ie, serum TT4 and cTSH >0.93 μg/dL and <0.5 mg/mL, respectively).
Moreover, these animals were considered to have normal cardiovascular health if results of echocardiographic examination were within normal limits and no rhythm disturbance (other than sinus arrhythmia or sinus tachycardia) was observed on ECG.
| Analytical procedures and thyroid evaluation
Serum cTSH concentrations were measured by use of a solid-part, 2-site chemiluminescent enzyme immunometric assay (IMMULITE 1000 Canine TSH; Diagnostic Products Corporation, Los Angeles, California). 21 The intra-assay coefficients of variation were 5.0%, 4%, and 3.8% at TSH concentrations of 0.20, 0.50, and 2.6 ng/mL, respectively. The interassay coefficients of variation were 6.3% and 8.2%
at TSH concentrations of 0.16 and 2.8 ng/mL, respectively. The sensitivity of the assay was 0.03 ng/mL. The upper limit of the reference range was 0.5 ng/mL. Serum TT4 concentrations were determined using a homologous solid-phase, chemiluminescent enzyme immunoassay (IMMULITE 1000 Canine total T4, Diagnostic Products Corporation). The intra-assay and interassay coefficients of variation were 3.9%-10.8% and 5.2%-13.8%, respectively. The sensitivity of the assay was 0.5 μg/dL. The reference range for TT4 was 0.93-2.87 μg/dL. To perform the rhTSH-stimulation test, serum TT4 was measured before and 6 hours after the IV administration of recombinant human TSHc at a dose of 75 μg per dog. 22 25 Echocardiographic images were obtained in awake animals using ultrasound units (CX50, Philips, Eindhoven, The Netherlands; iE33 ultrasound system, Philips Healthcare, Monza, Italy) equipped with 1-5 or 3-8 MHz phased-array transducers and simultaneous ECG trace recording, according to previously published standards. 26 An M-mode interrogation of the LV was performed from the right parasternal short-axis view at the level of the chordae tendineae, and measurements were obtained using the leading edge-to-leading edge method. 27 The LVDD and LVDS were indexed to the body weight (BW) according to Cornell's method 28 to obtain their normalized measurements (LVDDn and LVDSn, respectively). The LV FS was calculated according to the formula: FS = [(LVDD − LVDS)/LVDD] × 100. The mitral valve E point-to-septal separation (EPSS) was measured from M-mode images obtained from the short-axis view at the level of the mitral valve, as previously described in dogs. 29 Because EPSS is a linear dimension, mildly influenced by the weight of the animal, the absolute value then was indexed to BW (EPSSn) using the formula: EPSSn = (EPSS/BW 1/3 ). 28, 30 Left atrial (LA) and aortic root (Ao) diameters were measured using a 2D method from the right parasternal short-axis view at the heart base level in early diastole, and their ratio (LA/Ao) was calculated. 31 and <1.6, respectively). 28, 31 Each ECG and echocardiographic examination was reviewed by a board-certified cardiologist (M.B.T.) who performed all of the measurements.
| Cardiac evaluation
| Statistical analysis
All data were tested for their distribution using a D'Agostino-Pearson normality test. Normally distributed data are reported as mean ± standard deviation, and nonnormally distributed data are reported as median and range (minimum and maximum). 
Comparisons between ECG and echocardiographic variables
obtained at T0 and T60 in 30 hypothyroid dogs are summarized in hypothyroidism showed significantly increased HR (P < .001) and P-wave 
| DISCUSSION
We evaluated the effects of hypothyroidism on cardiac electric activity and mechanical function before and after levothyroxine supplementa- index of the global myocardial function combining both systolic and diastolic cardiac performance. The principal findings were that hypothyroid dogs had mild ECG and echocardiographic changes compared to clinically healthy dogs, and these cardiac changes improved after levothyroxine supplementation. Furthermore, the MPI was not significantly different neither between hypothyroid dogs at the time of diagnosis and control dogs nor in the former dogs before and after approximately 2 months of treatment. Although the effect of thyroid hormones on cardiac function has been investigated previously in dogs, 8, 9 ours is the first study comparing hypothyroid dogs with a control group of clinically healthy dogs.
The differential diagnosis of a dilated and hypokinetic LV is challenging in the dog, and the final diagnosis often can be achieved only by postmortem evaluation of the heart. 15 Therefore, evaluation of thyroid function has been suggested in the diagnostic evaluation to rule out hypothyroidism-induced cardiomyopathy. 15 Based on our results, this assumption likely should be reconsidered. Our findings are similar to those of a recent study focused on the evaluation of the relationship between hypothyroidism and DCM in Doberman
Pinschers. 33 In that study, a cause-effect relationship between the 2 diseases could not be identified, and the authors stated that hypothyroidism does not play any role in the etiology and progression of DCM. 33 Similarly, results of our study do not justify considering hypothyroid-induced cardiac changes as identical to DCM, because the observed echocardiographic changes were too mild to reflect clinically relevant cardiac dysfunction. Some isolated reports of dogs with clinically relevant cardiac dysfunction associated with hypothyroidism have been published previously. [3] [4] [5] [6] However, these cases were only sporadic compared to the overall prevalence of hypothyroidism in dogs. 34 It also must be considered that the diagnosis of hypothyroidism in dogs is often challenging, and the risk of misdiagnosing hypothyroidism in dogs with non-thyroidal illness syndrome is a major concern. 1,33,34 Dogs enrolled in our study represented a large cohort of hypothyroid dogs that were managed identically. In particular, all dogs underwent a standardized diagnostic protocol and all questionable cases received a rhTSH-stimulation test to obtain a definitive diagnosis. 22 Therefore, all dogs in our study had an ascertained diagnosis, but none of them showed clinical signs of cardiac disease nor had clinically relevant cardiac changes detected on ECG and echocardiography.
When systematically considering the measured ECG variables, mean HR was significantly decreased in the hypothyroid dogs at T0 compared to that of the control group, but only 1 hypothyroid dogs was bradycardic. Decreased HR in dogs with spontaneous and experimentally induced hypothyroidism has been reported, 7, 9, 11, 12 and may be caused by a direct effect of thyroid hormones on the myocardium, decrease in tissue oxygen consumption, or downregulation of β-adrenergic receptors causing a decreased response to sympathetic stimulation. 35 The P-and R-wave amplitudes also were significantly decreased in the hypothyroid group compared to those of the control group. In 2 previous studies, low R-waves were reported in 11 of 19 (58%) and in 24 of 66 (36%) of hypothyroid dogs. 8, 9 Although the exact cause of low R-wave amplitude is not known, obesity, decreased myocardial mass, or decreased circulating blood volume associated with hypothyroidism may be responsible for this ECG modification. 35 Finally, a significantly lower MEA of the QRS between hypothyroid dogs and the control group was noted. Changes in the MEA of the QRS may indicate ventricular chamber enlargement or intraventricular conduction disturbances, 23 [38] [39] [40] [41] [42] [43] [44] [45] These studies showed a significant increase in the LV MPI in dogs with symptomatic MMVD compared to control dogs and dogs with asymptomatic MMVD, 40 as well as in Newfoundland dogs with DCM compared to clinically healthy Newfoundland dogs, 38 whereas no difference was found in Boxer dogs with or without arrhythmogenic right ventricular cardiomyopathy. 43, 44 Furthermore, an increased LV and right ventricular MPI had negative prognostic value in dogs with parvovirus infection 45 and in dogs with MMVD, 42 respectively. Our results suggest that MPI has poor diagnostic usefulness in identifying either the subtle cardiac changes induced by hypothyroidism or the positive changes of levothyroxine supplementation. These findings are in contrast with those in humans with hypothyroidism, in whom measurement of MPI allowed identification of deterioration in cardiac function that was reversible after levothyroxine replacement. 17, 20 Our study had some limitations. First, it was a 2-center study and data were obtained by 2 independent observers (H.P. and 
